Literature DB >> 17170612

Achieving blood pressure goals: why aren't we?

William C Cushman1, Jan Basile.   

Abstract

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends a blood pressure (BP) goal of <140/90 mm Hg in patients with hypertension and <130/80 mm Hg in those with diabetes or chronic kidney disease. Achievement of BP goals is associated with significant benefits in cardiovascular morbidity and mortality. Although evidence suggests these goals are attainable, only about one third of patients are meeting them. There is a significant gap between treatment guideline recommendations and their implementation in clinical practice. Many clinicians appear satisfied with modest BP reductions and do not make the necessary treatment adjustments to achieve BP goals. Patient nonadherence is another important reason for lack of BP control. For the success of clinical trials to be reproduced in clinical practice, clinicians must recognize the importance of treating BP to goal, emphasize to patients the need to adhere to treatments, and provide persistent, goal-targeted therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17170612      PMCID: PMC8109639          DOI: 10.1111/j.1524-6175.2006.05789.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  52 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.

Authors:  Steven G Chrysant; Thomas C Marbury; Tonous N Silfani
Journal:  Blood Press Monit       Date:  2006-06       Impact factor: 1.444

6.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

Authors:  Fiona Turnbull; Bruce Neal; Charles Algert; John Chalmers; Neil Chapman; Jeff Cutler; Mark Woodward; Stephen MacMahon
Journal:  Arch Intern Med       Date:  2005-06-27

Review 7.  Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?

Authors:  Brent M Egan; Jan N Basile
Journal:  J Investig Med       Date:  2003-11       Impact factor: 2.895

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

Authors:  Athanase Benetos; Frédérique Thomas; Kathryn E Bean; Louis Guize
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

View more
  22 in total

1.  Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.

Authors:  Nelson Wang; Abdul Salam; Ruth Webster; Asita de Silva; Rama Guggilla; Sandrine Stepien; Jayanthi Mysore; Laurent Billot; Stephen Jan; Pallab K Maulik; Nitish Naik; Vanessa Selak; Simon Thom; Dorairaj Prabhakaran; Anushka Patel; Anthony Rodgers
Journal:  JAMA Cardiol       Date:  2020-11-01       Impact factor: 14.676

2.  Diagnosis and Control of Hypertension in the Elderly Populations of Japan and the United States.

Authors:  Yasuhiko Saito; Shieva Davarian; Atsuhiko Takahashi; Edward Schneider; Eileen M Crimmins
Journal:  Int J Popul Stud       Date:  2015-12-31

3.  Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration.

Authors:  Francesco Rozza; Valentina Trimarco; Raffaele Izzo; Mario Santoro; Maria Virginia Manzi; Marina Marino; Gianfranco Di Renzo; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-05-09

4.  Feasibility of an interdisciplinary program for obesity management in Canada.

Authors:  Sean Wharton; Sarah VanderLelie; Arya M Sharma; Saaqshi Sharma; Jennifer L Kuk
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 5.  The importance of potassium in managing hypertension.

Authors:  Mark C Houston
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

6.  Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study.

Authors:  John W Graves; Carole L White; Jeff M Szychowski; Pablo E Pergola; Oscar R Benavente; Christopher S Coffey; Lindsey N Hornung; Robert G Hart
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

7.  Diuretic use in black patients with uncontrolled hypertension.

Authors:  Linda M Gerber; Samuel J Mann; Margaret V McDonald; Ya-Lin Chiu; Sridevi Sridharan; Penny H Feldman
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

8.  Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.

Authors:  Martial G Bourassa; Colin Berry
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

9.  Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.

Authors:  Richard Ian Ogilvie; Sanjiv Anand; Pierre Roy; Selwyn De Souza
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 10.  Using fixed-dose combination therapies to achieve blood pressure goals.

Authors:  Steven G Chrysant
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.